XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ (11,694,964) $ 113,613,952
Net income from discontinued operation (2,647,316) 119,264,056
Net loss from continuing operations (9,047,648) (5,650,104)
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation 14,018 1,073
Amortization 3,750 80,733
Provision for doubtful debts (15,255) 243,022
Share-based payments 6,381,180 1,191,000
Interest expenses related to convertible note (96,691)
Changes in operating assets and liabilities    
Accounts receivable (8,290,510)
Inventory 156
Other receivable (1,690,100) 3,901,022
Advances to suppliers and other current assets (5,642,045) 1,627,148
Accounts payable 1,211,045 439
Due to related parties
Accrued expenses (1,398,587) (688,037)
Advances from customers (26,118) (342,511)
Proceeds from amounts due from related parties, net 319,953 197,476
Repayment of amounts due to related parties, net (1,535,238)
Net Cash Used in Operating Activities – Continued Operations (19,812,246) 561,417
Net Cash Used in Operating Activities – Discontinued Operations 2,222,678 (9,543,323)
CASH FLOWS FROM INVESTING ACTIVITIES    
Additions to property, plant and equipment (614,720) (2,944)
Payment for Loan receivables (6,308,385)
Acquisition of a subsidiary - NTAM, net of cash 275,427
Disposal of a subsidiary - Guangchengji, net of cash (59,255)
Purchase of intangible assets (1,860,606)
Net Cash Used in Investing Activities from Discontinued Operations (6,706,933) (1,863,550)
Net Cash Used in Investing Activities from Continuing Operations
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the issuance of common stock, net of issuance costs 69,430,439 920,001
Proceeds from loan payable   746,663
Proceeds from secured convertible promissory note 8,425,685
Repayment of convertible payable (1,163,146)
Net cash provided by financing activities 68,267,293 10,092,349
Effect of change in exchange rate (426,748) 1,183,939
NET INCREASE IN CASH AND CASH EQUIVALENTS 43,544,044 430,832
Cash and cash equivalents, beginning of period 9,425,312 526,844
Cash and cash equivalents, end of period 52,969,356 957,676
Less: Cash and cash equivalents from the discontinued operations, end of period 516 933,822
Cash and cash equivalents, from the continuing operations end of period 52,968,840 23,854
SUPPLEMENTARY DISCLOSURE OF SIGNIFICANT NON-CASH TRANSACTION    
Issuance of common stocks (Note 9) 11,220,779
Deferred liabilities (Note 9) 7,007,512  
Debt settlement by issuance of common stock   4,961,000
Issuance of common stocks for conversion of debts $ 700,236